{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Bugge C"],"funding":["Norges Forskningsråd","Bristol-Myers Squibb"],"pagination":["e050564"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8477316"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["11(9)"],"pubmed_abstract":["<h4>Objectives</h4>The objective of this study was to investigate the use of, and predictors for, pharmaceutical anticancer treatment (PACT) towards the end of a patient's life in a country with a public healthcare system.<h4>Design</h4>Retrospective registry study.<h4>Setting</h4>Secondary care in Norway.<h4>Participants</h4>All Norwegian patients with cancer (International Classification of Diseases tenth revision (ICD-10) codes C00-99, D00-09, D37-48) in contact with a somatic hospital in Norway between 2009 and 2017 (N=420 655). Analyses were performed on a subsample of decedents with follow-back time of more than 1 year (2013-2017, N=52 496).<h4>Interventions</h4>N/A.<h4>Primary and secondary outcome measures</h4>Proportion of patients receiving PACT during the last year and month of "],"journal":["BMJ open"],"pubmed_title":["What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study."],"pmcid":["PMC8477316"],"funding_grant_id":["272493"],"pubmed_authors":["Sæther EM","Kaasa S","Bugge C","Melberg HO","Sonbo Kristiansen I"],"additional_accession":[]},"is_claimable":false,"name":"What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study.","description":"<h4>Objectives</h4>The objective of this study was to investigate the use of, and predictors for, pharmaceutical anticancer treatment (PACT) towards the end of a patient's life in a country with a public healthcare system.<h4>Design</h4>Retrospective registry study.<h4>Setting</h4>Secondary care in Norway.<h4>Participants</h4>All Norwegian patients with cancer (International Classification of Diseases tenth revision (ICD-10) codes C00-99, D00-09, D37-48) in contact with a somatic hospital in Norway between 2009 and 2017 (N=420 655). Analyses were performed on a subsample of decedents with follow-back time of more than 1 year (2013-2017, N=52 496).<h4>Interventions</h4>N/A.<h4>Primary and secondary outcome measures</h4>Proportion of patients receiving PACT during the last year and month of ","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Sep","modification":"2025-04-04T20:12:24.4Z","creation":"2022-02-11T11:56:29.555Z"},"accession":"S-EPMC8477316","cross_references":{"pubmed":["34580099"],"doi":["10.1136/bmjopen-2021-050564"]}}